A Randomized Trial of Vaccine Adherence in Young Injection Drug Users
NCT00244374 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 546
Last updated 2013-09-30
Summary
The purpose of this study is to compare the effects of (a) immunization setting and (b) outreach worker support on young injection drug users' (IDU) adherence to a multiple dose immunization schedule with a combined hepatitis A virus (HAV) inactivated and hepatitis B virus (HBV) recombinant vaccine.
Conditions
- Medication Adherence
- Substance Abuse, Intravenous
- Risk Behavior
- Hepatitis A
- Hepatitis B
- Hepatitis C
Interventions
- BIOLOGICAL
-
Hepatitis A & B vaccine
Each subject will receive a total of 4 immunizations over 6 months on a 0-1-2-6 month schedule. At the initial visit, subjects\>18 years of age will receive the Twinrix vaccine and subjects\<18 years of age will receive the Engerix-B vaccine. Cohort subjects\>18 years found to have HAV antibody at screening will receive Engerix-B for their remaining 3 immunizations. All subjects will receive: an immunization record with the first vaccine dose entered and the dates the next doses are due; helpful hints for remembering vaccine appointments; and written instructions on where and how to get immunized outside of SF.
- BEHAVIORAL
-
Outreach
Outreach worker vaccine adherence support: Half of cohort subjects will be assigned to outreach worker vaccine adherence support and will meet with their outreach workers from Haight Ashbury Youth Outreach Team (HAYOT) and Glide Health Services on the day of vaccine cohort study enrollment. Intensive vaccination tracking and in-person outreach support will begin one week before the second and third vaccine doses are due, and again two weeks before the fourth dose is due.
- BEHAVIORAL
-
AIC
The Adult Immunization Clinic (AIC) is a public low-cost vaccine clinic located centrally at 101 Grove Street in the lobby of the San Francisco Department of Public Health (SFDPH). The clinic is open from Monday-Friday 9 a.m. to 4 p.m. Nurses at the AIC will be available 40 hours/week to administer free immunizations to study subjects.
- BEHAVIORAL
-
SEP
Subjects randomized to a set of syringe exchange programs for administration of viral hepatitis immunizations at Month 1, 2, 6. Research nurses will provide 16 hours/week of vaccine administration services at SEPs well attended by young IDU. The San Francisco Needle Exchange (SFNE) serves primarily youth and young adults on Mondays, Wednesdays, and Fridays from 5-7 p.m. in an indoor location in the Haight-Ashbury district. A study nurse will be at SFNE for a total of 6 hours per week. HIV Prevention Project (HPP) sites also operate for 2 hrs each (Tues, Thu, Fri, Sat). Medical services are provided either in a clinic setting at indoor sites (6th Street) or at outdoor sites (Hemlock Alley, Duboce). A study nurse will attend each of these 5 weekly sites for a total of 10 hours/week.
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Paula J Lum, M.D., M.P.H. · University of California, San Francisco
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 14 Years
- Max Age
- 29 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-08-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-06-30
Countries
- United States
Study Locations
More Related Trials
-
Effective Treatment of Hepatitis C in Substance Users
NCT00633243 ·Status: COMPLETED ·Phase: NA
-
Coaching for HCV and HIV
NCT04314414 ·Status: COMPLETED ·Phase: NA
-
Medication Adherence Therapy for Opioid Abusing Pain Patients
NCT00249587 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mobile Intervention for Young Opioid Users
NCT03610672 ·Status: UNKNOWN ·Phase: NA
-
Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1
NCT00218634 ·Status: COMPLETED ·Phase: NA
-
Peer Supported Collaborative Care Mental Health and Substance Use Disorder Care
NCT04601064 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Motivation, Syringe Exchange, and COVID-19
NCT05534061 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Maintenance for Opioid Addicts - 3
NCT00000204 ·Status: COMPLETED ·Phase: PHASE2
-
A Setting Focus Overdose Prevention Intervention
NCT05320835 ·Status: RECRUITING ·Phase: NA
-
Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1
NCT00000216 ·Status: COMPLETED ·Phase: PHASE3
-
The Youth Opioid Recovery Support (YORS) Intervention
NCT04173416 ·Status: RECRUITING ·Phase: NA
-
Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users
NCT00270257 ·Status: TERMINATED ·Phase: PHASE3
-
Application Based Addiction Treatment Adherence Trial
NCT04680741 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients
NCT03962816 ·Status: UNKNOWN ·Phase: PHASE4
-
Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients
NCT02991599 ·Status: COMPLETED ·Phase: PHASE4
-
Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial
NCT00684554 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Adherence Monitoring For Substance Abuse Clinical Trials
NCT01867476 ·Status: COMPLETED
-
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
NCT05286879 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine Integration Research and Community Health
NCT05668780 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior
NCT03221309 ·Status: COMPLETED
-
Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance
NCT00622596 ·Status: COMPLETED ·Phase: NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
NCT05343169 ·Status: RECRUITING ·Phase: NA
-
Buprenorphine and Integrated HIV Care
NCT00317460 ·Status: COMPLETED ·Phase: PHASE4
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
NCT03135886 ·Status: RECRUITING ·Phase: NA
-
Mobile Psychosocial Interventions for MMT Clients
NCT01632982 ·Status: UNKNOWN ·Phase: NA